{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:09:02Z","timestamp":1787594942772,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00213-023-06450-3","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T17:02:47Z","timestamp":1692723767000},"page":"2561-2571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pharmaco-EEG analysis of ligands varying in selectivity for \u03b11 subunit-containing GABAA receptors during the active phase in rats"],"prefix":"10.1007","volume":"240","author":[{"given":"Jaren A.","family":"Reeves-Darby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lais F.","family":"Berro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"R\u00fcedi-Bettschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Shaffery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4077-5017","authenticated-orcid":false,"given":"James K.","family":"Rowlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"6450_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/0269881109354928","volume":"25","author":"JR Atack","year":"2011","unstructured":"Atack JR, Hallett DJ, Tye S, Wafford KA, Ryan C, Sanabria-Boh\u00f3rquez SM, Eng WS, Gibson RE, Burns HD, Dawson GR, Carling RW, Street LJ, Pike A, De Lepeleire I, Van Laere K, Bormans G, de Hoon JN, Van Hecken A, McKernan RM et al (2011) Preclinical and clinical pharmacology of TPA023B, a GABAA receptor \u03b12\/\u03b13 subtype-selective partial agonist. J Psychopharmacol 25:329\u2013344","journal-title":"J Psychopharmacol"},{"key":"6450_CR2","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1038\/npp.2016.49","volume":"41","author":"LM Behlke","year":"2016","unstructured":"Behlke LM, Foster RA, Liu J, Benke D, Benham RS, Nathanson AJ, Yee BK, Zeilhofer HU, Engin E, Rudolph U (2016) A pharmacogenetic \u201crestriction-of-function\u201d approach reveals evidence for anxiolytic-like actions mediated by \u03b15-containing GABAA receptors in mice. Neuropsychopharmacology 41:2492\u20132501","journal-title":"Neuropsychopharmacology"},{"key":"6450_CR3","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00213-021-05793-z","volume":"238","author":"LF Berro","year":"2021","unstructured":"Berro LF, Overton JS, Reeves-Darby JA, Rowlett JK (2021) Alprazolam-induced EEG spectral power changes in rhesus monkeys: a translational model for the evaluation of the behavioral effects of benzodiazepines. Psychopharmacology (Berl) 238:1373\u20131386","journal-title":"Psychopharmacology (Berl)"},{"key":"6450_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/acer.14000","volume":"43","author":"LF Berro","year":"2019","unstructured":"Berro LF, R\u00fcedi-Bettschen D, Cook JE, Golani LK, Li G, Jahan R, Rashid F, Cook JM, Rowlett JK, Platt DM (2019) GABAA receptor subtypes and the abuse-related effects of ethanol in rhesus monkeys: experiments with selective positive allosteric modulators. Alcohol Clin Exp Res 43:791\u2013802","journal-title":"Alcohol Clin Exp Res"},{"key":"6450_CR5","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/0006-3223(85)90208-2","volume":"20","author":"MS Buchsbaum","year":"1985","unstructured":"Buchsbaum MS, Hazlett E, Sicotte N, Stein M, Wu J, Zetin M (1985) Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder. Biol Psychiatry 20:832\u2013842","journal-title":"Biol Psychiatry"},{"key":"6450_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108035","volume":"234","author":"R Cerne","year":"2022","unstructured":"Cerne R, Lippa A, Poe MM, Smith JL, Jin X, Ping X, Golani LK, Cook JM, Witkin JM (2022) GABAkines\u2014advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors. Pharmacol Ther 234:108035","journal-title":"Pharmacol Ther"},{"key":"6450_CR7","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/bcp.12413","volume":"78","author":"X Chen","year":"2014","unstructured":"Chen X, Jacobs G, de Kam M, Jaeger J, Lappalainen J, Maruff P, Smith MA, Cross AJ, Cohen A, van Gerven J (2014) The central nervous system effects of the partial GABA-A\u03b12,3 -selective receptor modulator AZD7325 in comparison with lorazepam in healthy males. Br J Clin Pharmacol 78:1298\u20131314","journal-title":"Br J Clin Pharmacol"},{"key":"6450_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1152\/jn.00539.2013","volume":"113","author":"EP Christian","year":"2015","unstructured":"Christian EP, Snyder DH, Song W, Gurley DA, Smolka J, Maier DL, Ding M, Gharahdaghi F, Liu XF, Chopra M, Ribadeneira M, Chapdelaine MJ, Dudley A, Arriza JL, Maciag C, Quirk MC, Doherty JJ (2015) E EG-\u03b2\/\u03b3 spectral power elevation in rat: a translatable biomarker elicited by GABAA\u03b12\/3-positive allosteric modulators at non-sedating anxiolytic doses. J Neurophysiol 113:116\u2013131","journal-title":"J Neurophysiol"},{"key":"6450_CR9","first-page":"464","volume":"14","author":"AM Coenen","year":"1991","unstructured":"Coenen AM, van Luijtelaar EL (1991) Pharmacological dissociation of EEG and behavior: a basic problem in sleep-wake classification. Sleep 14:464\u2013465","journal-title":"Sleep"},{"issue":"5 Suppl","key":"6450_CR10","first-page":"S16","volume":"15","author":"CJ Davis","year":"2011","unstructured":"Davis CJ, Clinton JM, Jewett KA, Zielinski MR, Krueger JM (2011) Delta wave power: an independent sleep phenotype or epiphenomenon? J Clin Sleep Med 15(5 Suppl):S16\u2013S18","journal-title":"J Clin Sleep Med"},{"key":"6450_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0014-2999(89)90109-X","volume":"171","author":"DJ Dijk","year":"1989","unstructured":"Dijk DJ, Beersma DG, Daan S, van den Hoofdakker RH (1989) Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra. Eur J Pharmacol 171:207\u2013218","journal-title":"Eur J Pharmacol"},{"key":"6450_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000443175","volume":"72","author":"WH Drinkenburg","year":"2015","unstructured":"Drinkenburg WH, Ahnaou A, Ruigt GS (2015a) Pharmaco-EEG studies in animals: a history-based introduction to contemporary translational applications. Neuropsychobiology 72:139\u2013150","journal-title":"Neuropsychobiology"},{"key":"6450_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000442210","volume":"72","author":"WHIM Drinkenburg","year":"2016","unstructured":"Drinkenburg WHIM, Ruigt GSF, Ahnaou A (2015b) Pharmaco-EEG studies in animals: an overview of contemporary translational applications. Neuropsychobiology 72:151\u2013164","journal-title":"Neuropsychobiology"},{"key":"6450_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1124\/jpet.118.249250","volume":"366","author":"AN Duke","year":"2018","unstructured":"Duke AN, Meng Z, Platt DM, Atack JR, Dawson GR, Reynolds DS, Tiruveedhula VVNPB, Li G, Stephen MR, Sieghart W, Cook JM, Rowlett JK (2018) Evidence that sedative effects of benzodiazepines involve unexpected GABAA receptor subtypes: quantitative observation studies in rhesus monkeys. J Pharmacol Exp Ther 366:145\u2013157","journal-title":"J Pharmacol Exp Ther"},{"key":"6450_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.tips.2018.04.003","volume":"39","author":"E Engin","year":"2018","unstructured":"Engin E, Benham RS, Rudolph U (2018) An emerging circuit pharmacology of GABAA receptors. Trends Pharmacol Sci 39:710\u2013732","journal-title":"Trends Pharmacol Sci"},{"key":"6450_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43141-020-00094-y","volume":"19","author":"A Ghit","year":"2021","unstructured":"Ghit A, Assal D, Al-Shami AS, Hussein DEE (2021) GABAA receptors: structure, function, pharmacology, and related disorders. J Gen Eng Biotech 19:1\u201315","journal-title":"J Gen Eng Biotech"},{"key":"6450_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/0269881107077733","volume":"21","author":"C Gilles","year":"2007","unstructured":"Gilles C, Luthringer R (2007) Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs. J Psychopharmacol (Oxf) 21:272\u2013282","journal-title":"J Psychopharmacol (Oxf)"},{"key":"6450_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0304-3940(00)01496-8","volume":"293","author":"ML Jongsma","year":"2000","unstructured":"Jongsma ML, van Rijn CM, van Egmond J, van Schaijk WJ, Sambeth A, Coenen AM (2000) The influence of diazepam on the electroencephalogram-evoked potential interrelation in rats. Neurosci Lett 293:83\u201386","journal-title":"Neurosci Lett"},{"key":"6450_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.coph.2021.04.003","volume":"59","author":"F Knoflach","year":"2021","unstructured":"Knoflach F, Bertrand D (2021) Pharmacological modulation of GABAA receptors. Curr Op Pharmacol 59:3\u201310","journal-title":"Curr Op Pharmacol"},{"key":"6450_CR20","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1046\/j.1460-9568.2003.02651.x","volume":"17","author":"C Kopp","year":"2003","unstructured":"Kopp C, Rudolph U, Keist R, Tobler I (2003) Diazepam-induced changes on sleep and the EEG spectrum in mice: role of \u03b13-GABAA receptor subtype. Eur J Neurosci 17:2226\u20132230","journal-title":"Eur J Neurosci"},{"key":"6450_CR21","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1073\/pnas.0306975101","volume":"101","author":"C Kopp","year":"2004","unstructured":"Kopp C, Rudolph U, L\u00f6we K, Tobler I (2004) Modulation of rhythmic brain activity by diazepam: GABAA receptor subtype and state specificity. Proc Natl Acad Sci USA 101:3674\u20133679","journal-title":"Proc Natl Acad Sci USA"},{"key":"6450_CR22","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.bcp.2010.10.002","volume":"81","author":"SC Leiser","year":"2011","unstructured":"Leiser SC, Dunlop J, Bowlby MR, Devilbliss DM (2011) Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research. Biochem Pharmacol 81:1408\u20131421","journal-title":"Biochem Pharmacol"},{"key":"6450_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/00000542-199601000-00007","volume":"84","author":"J Liu","year":"1996","unstructured":"Liu J, Singh H, White PF (1996) Electroencephalogram bispectral analysis predicts the depth of midazolam-induced sedation. Anesthesiology 84:64\u201369","journal-title":"Anesthesiology"},{"key":"6450_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/75761","volume":"3","author":"RM McKernan","year":"2000","unstructured":"McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, Farrar S, Myers J, Cook G, Ferris P, Garrett L, Bristow L, Marshall G, Macaulay A, Brown N, Howell O, Moore KW, Carling RW, Street LJ et al (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 3:587\u2013592","journal-title":"Nat Neurosci"},{"key":"6450_CR25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/0269881119882803","volume":"34","author":"Z Meng","year":"2020","unstructured":"Meng Z, Berro LF, Sawyer EK, R\u00fcedi-Bettschen D, Cook JE, Li G, Platt DM, Cook JM, Rowlett JK (2020) Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for\u2009\u03b13 subunit-containing GABAA receptors. J Psychopharmacol 34:348\u2013357","journal-title":"J Psychopharmacol"},{"key":"6450_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/bph.14119","volume":"175","author":"SA Nickolls","year":"2018","unstructured":"Nickolls SA, Gurrell R, van Amerongen G, Kammonen J, Cao L, Brown AR, Stead C, Mead A, Watson C, Hsu C, Owen RM, Pike A, Fish RL, Chen L, Qiu R, Morris ED, Feng G, Whitlock M, Gorman D et al (2018) Pharmacology in translation: the preclinical and early clinical profile of the novel \u03b12\/3 functionally selective GABAA receptor positive allosteric modulator PF-06372865. Br J Pharmacol 175:708\u2013725","journal-title":"Br J Pharmacol"},{"key":"6450_CR27","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1073\/pnas.0405621102","volume":"102","author":"JK Rowlett","year":"2005","unstructured":"Rowlett JK, Platt DM, Lelas S, Atack JR, Dawson GR (2005) Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc Natl Acad Sci USA 102:915\u2013920","journal-title":"Proc Natl Acad Sci USA"},{"key":"6450_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/155005940603700205","volume":"37","author":"B Saletu","year":"2006","unstructured":"Saletu B, Anderer P, Saletu-Zyhlarz GM (2006) EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs. Clin EEG Neurosci 37:66\u201380","journal-title":"Clin EEG Neurosci"},{"key":"6450_CR29","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1073\/pnas.111055398","volume":"98","author":"I Tobler","year":"2001","unstructured":"Tobler I, Kopp C, Deboer T, Rudolph W (2001) Diazepam-induced changes in sleep: role of the \u03b11GABAA receptor subtype. Proc Natl Acad Sci USA 98:6464\u20136469","journal-title":"Proc Natl Acad Sci USA"},{"key":"6450_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuropharm.2004.03.017","volume":"47","author":"H van Lier","year":"2004","unstructured":"van Lier H, Drinkenburg WH, van Eeten YJ, Coenen AM (2004) Effects of diazepam and zolpidem on EEG beta frequencies are behavior-specific in rats. Neuropharmacology 47:163\u2013174","journal-title":"Neuropharmacology"},{"key":"6450_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000119230","volume":"32","author":"M Versavel","year":"1995","unstructured":"Versavel M, Leonard JP, Herrmann WM (1995) Standard operating procedure for the registration and computer-supported evaluation of pharmaco-EEG data. 'EEG in Phase I' of the Collegium Internationale Psychiatriae Scalarum (CIPS). Neuropsychobiology 32:166\u2013170","journal-title":"Neuropsychobiology"},{"key":"6450_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1124\/jpet.102.042341","volume":"304","author":"SAG Visser","year":"2003","unstructured":"Visser SAG, Wolters FLC, Gubbens-Stibbe JM, Tukker E, Van der Graaf PH, Peletier LA, Danhof M (2003) Mechanism-based PK\/PD modelling of the EEG effects of GABAA receptor modulators: in vitro\/in vivo correlations. J Pharmacol Exp Ther 304:88\u2013101","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06450-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-023-06450-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06450-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T16:02:57Z","timestamp":1699718577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-023-06450-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["6450"],"URL":"https:\/\/doi.org\/10.1007\/s00213-023-06450-3","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"assertion":[{"value":"18 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}